摘要
目的:探讨疏血通辅助治疗重症肺炎的临床疗效。方法:将65例重症肺炎按随机数字表法分为治疗组34例和对照组31例,对照组采用呼吸机辅助呼吸、抗感染、化痰、营养支持等常规治疗,治疗组在此基础上联合疏血通注射液治疗。结果:两组CPIS、APACHE II评分、CRP、PCT、D-二聚体均较治疗前有所改善,但治疗组改善程度优于对照组,差异有统计学意义(P<0.05),且治疗组较对照组能明显减少死亡率、缩短呼吸机辅助呼吸、血管活性药物使用时间,差异有统计学意义(P<0.05)。结论:疏血通注射液辅助治疗重症肺炎安全有效。
Objective: To investigate clinical effects of the Shuxuetong injection on severe pneumonia. Methods: 65 patients with severe pneumonia were divided into the treatment group (n=34) and the control group (n=31) according to random number table. The control group was given conventional treatment such as ventilator-assisted breathing, anti-infection, phlegm reduction, nutritional support, etc. The treatment group was given the Shuxuetong injection more. Results: CPIS, APACHE II score, CRP, PCT, D-dimer in two groups were all improved, but the improving degree in the treatment group was better than that in the control group, the difference was statistically significant (P<0.05). Mortality rate in the treatment group was lower. Additionally, time of mechanical ventilation, and vasoactive drugs in the treatment group were lower than that in the control group (P<0.05). Conclusion: The Shuxuetong injection was effective on severe pneumonia, with high safety.
出处
《中医临床研究》
2015年第16期50-52,共3页
Clinical Journal Of Chinese Medicine
基金
广东省广州市番禺区科技局计划项目(编号2012-Z-03-22)
关键词
疏血通注射液
重症肺炎
凝血功能
The shuxuetong injection
Severe pneumonia
Coagulation function
